Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
Mirum Pharmaceuticals, Inc.
Mirum Pharmaceuticals, Inc.
MIRM
Valuace
70
Růst
40
Zdraví
75
Cena
$ 68.58
Dnes
--1.27 (-1.38%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
3.4B
Obrat
1B
Zisk
0B
Aktiva
1B
Dluh
0B
ROE
-14%
ROA
-5%
PE
-140
PS
12
Cena 1R
37-94
⌀ Cena
61.56
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
25-02-2026
Poslední dividenda

Profil

Mirum Pharmaceuticals, Inc., biofarmaceutická společnost, se zaměřuje na vývoj a komercializaci nových terapií pro vysilující vzácná a vzácná onemocnění. Hlavním kandidátem na přípravek je LIVMARLI, hodnocený perorální lék pro léčbu progresivní familiární intrahepatální cholestázy, stejně jako pro léčbu Alagillova syndromu a onemocnění žlučových cest. Dále vyvíjí přípravek Volixibat pro léčbu intrahepatální cholestázy březosti a primární sklerotizační cholangitidy. Společnost Mirum Pharmaceuticals, Inc. byla založena v roce 2018 a sídlí ve Foster City v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
334
Založení
2019-07-18
Adresa
950 Tower Lane
CEO
Christopher Peetz
Web
www.mirumpharma.com

Podobné společnosti

BLTE
Belite Bio, Inc
$ 112.96
- $ 0.23
LGND
Ligand Pharmaceuticals Incorporated
$ 203.65
+ $ 1.17
ADMA
ADMA Biologics, Inc.
$ 14.45
- $ 0.08
PRAX
Praxis Precision Medicines, Inc.
$ 166.74
- $ 1.48
ACAD
ACADIA Pharmaceuticals Inc.
$ 22.42
- $ 0.15
TVTX
Travere Therapeutics, Inc.
$ 33.60
+ $ 1.26
RARE
Ultragenyx Pharmaceutical Inc.
$ 30.45
- $ 0.18

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019
Total Revenues521.3521.3336.9186.477.119.10.00.0
Cost of Revenues100.3100.681.647.012.41.90.00.0
Gross Profit421.0420.7255.2139.364.717.20.00.0
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues148.9133.0127.8111.699.490.477.969.269.647.7
Cost of Revenues28.325.523.423.022.820.820.217.822.610.2
Gross Profit120.6107.5104.488.676.669.657.651.447.037.5
Operating Income TTM 2025202420232022202120202019
R&D Expenses0.00.00.0102.6106.8131.481.643.0
Selling General & Admin Expenses0.00.00.0145.989.159.222.711.8
Depreciation & Amortization24.224.223.610.84.2108.81.40.3
Total Operating Expenses443.2443.2342.9248.5195.9190.6104.354.7
Operating Income-22.1-22.1-87.6-109.2-131.2-173.4-104.3-54.7
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.030.826.1
Selling General & Admin Expenses0.00.00.00.00.00.00.00.046.236.5
Depreciation & Amortization6.16.16.16.16.16.15.95.75.42.7
Total Operating Expenses125.2104.9109.4103.8100.982.381.977.977.062.6
Operating Income-4.62.6-5.0-15.2-24.2-12.7-24.2-26.5-30.1-25.1
Net Income TTM 2025202420232022202120202019
Interest Income12.712.713.813.73.90.41.62.2
Interest Expense14.414.414.315.116.017.60.30.0
Other Expense0.70.70.7-53.3-10.989.51.02.2
IBT-21.4-21.4-86.9-162.4-142.1-84.0-103.3-52.5
Income Tax Expense1.91.91.01.0-6.40.00.00.0
Net Income-23.4-23.4-87.9-163.4-135.7-84.0-103.3-52.6
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income3.43.33.03.03.23.53.53.63.84.1
Interest Expense3.63.63.63.63.63.63.63.63.63.6
Other Expense-0.40.0-0.51.5-0.1-1.20.21.8-2.81.8
IBT-5.02.6-5.5-13.6-24.4-13.9-24.0-24.7-32.9-23.3
Income Tax Expense0.8-0.30.41.0-0.60.30.60.60.20.2
Net Income-5.72.9-5.9-14.7-23.8-14.2-24.6-25.3-33.1-23.6
Per Share Data TTM 2025202420232022202120202019
EPS$0.00$0.00$0.00$-4.00$-4.01$-2.77$-4.09$-4.58
EPS Diluted$0.00$0.00$0.00$-4.00$-3.99$-2.77$-4.09$-4.58
Shares Outstanding50.250.247.540.933.830.325.311.5
Diluted Shares Outstanding50.250.247.540.934.030.325.311.5
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.71$-0.57
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.71$-0.57
Shares Outstanding50.258.149.748.948.347.847.246.946.741.1
Diluted Shares Outstanding50.257.049.748.948.347.847.246.946.741.1
Current Assets TTM 2024202320222021202020192018
Cash And Equivalents233.2222.5286.328.031.3142.1140.052.0
Short Term Investments45.157.80.0123.7125.289.7104.70.0
Total Cash & ST Investments278.4280.3286.3251.7156.5231.8140.052.0
Accounts Receivable60.478.368.024.03.30.00.00.0
Inventory20.422.422.35.61.50.00.00.0
Other Current Assets8.611.810.98.95.34.52.70.0
Total Current Assets367.8392.8387.5190.2166.6236.4119.452.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents282.0228.1211.8222.5223.0233.2302.8286.3303.1297.2
Short Term Investments93.576.465.957.861.545.10.00.03.032.7
Total Cash & ST Investments375.5304.6277.7280.3284.4278.4302.8286.3306.0330.0
Accounts Receivable107.1106.895.978.368.560.455.068.047.835.3
Inventory24.022.922.422.421.620.421.622.322.38.5
Other Current Assets23.919.114.911.812.18.610.010.912.59.7
Total Current Assets530.6453.4410.8392.8386.6367.8389.5387.5388.6383.5
Long-Term Assets TTM 2024202320222021202020192018
Net Property, Plant & Equipment9.99.82.02.32.63.23.70.0
Goodwill0.00.00.00.00.00.00.00.0
Intangible Assets261.8249.8252.959.018.70.00.00.0
Long-Term Investments17.312.50.00.05.00.023.30.0
Other Long-Term Assets4.05.84.2101.4101.81.30.30.0
Total Long-Term Assets292.9278.0259.1162.7128.14.527.30.0
Total Assets660.8670.8646.6352.9294.7240.9146.752.0
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment9.810.18.89.810.39.91.22.02.22.5
Goodwill0.00.00.00.00.00.00.00.00.00.0
Intangible Assets231.9237.9243.8249.8255.8261.8257.4252.9258.356.4
Long-Term Investments2.517.120.912.59.317.10.00.00.00.0
Other Long-Term Assets10.47.35.95.85.84.23.94.21.51.2
Total Long-Term Assets254.5272.4279.4278.0281.3292.9262.5259.1262.160.1
Total Assets785.1725.8690.2670.8667.9660.8652.0646.6650.6443.6
Current Liabilities TTM 2024202320222021202020192018
Accounts Payable9.814.67.48.79.23.23.40.3
Short-Term Debt1.11.72.20.90.70.60.40.0
Other Current Liabilities101.4110.277.455.12.01.39.32.2
Current Liabilities112.3126.687.164.742.618.513.12.4
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable12.217.711.614.69.59.816.07.47.414.4
Short-Term Debt2.02.11.61.71.51.10.42.22.22.1
Other Current Liabilities146.2125.1114.3110.2104.7101.489.677.465.141.6
Current Liabilities160.4144.8127.6126.6115.8112.3105.987.174.758.2
Long-Term Liabilities TTM 2024202320222021202020192018
Long-Term Debt307.2316.1307.01.31.92.63.30.0
Capital Leases8.29.71.72.22.63.33.60.0
Def. Tax Liability0.00.00.00.00.00.00.00.0
Total Liabilities431.8445.1398.0210.9174.468.816.462.3
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt316.7316.8315.5316.1316.1315.5307.2307.0306.9307.9
Capital Leases9.410.08.69.710.09.30.70.62.02.2
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities493.1470.7457.0445.1435.9431.8417.4398.0381.6365.0
Total Common Equity TTM 2024202320222021202020192018
Common Stock0.00.00.00.00.00.00.07.0
Retained Earnings-606.2-644.2-556.2-392.8-257.2-173.2-69.9-17.3
Comprehensive Income-0.5-0.41.6-0.20.00.10.10.0
Total Common Equity229.0225.6248.7-392.8120.2-173.2-69.9-10.3
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.00.00.00.00.00.00.00.00.0
Retained Earnings-661.8-664.7-658.9-644.2-620.4-606.2-581.5-556.2-520.6-497.0
Comprehensive Income0.00.4-0.3-0.40.9-0.50.01.6-1.50.1
Total Common Equity292.0255.2233.3225.6232.0229.0234.6248.7269.1-497.0
Other TTM 2024202320222021202020192018
Total Debt316.6317.8308.12.22.63.33.60.0
Book Value229.0225.6248.7142.0120.2172.1130.3-10.3
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value292.0255.2233.3225.6232.0229.0234.6248.7269.1-497.0
Cash Flow From Operating Activities TTM 2025202420232022202120202019
Net Income-106.7-23.4-87.9-163.4-135.7-84.0-103.3-52.6
Depreciation & Amortization19.624.223.610.83.71.00.60.3
Stock-Based Compensation41.471.448.435.027.023.112.66.1
Change Working Capital4.4-19.722.6-22.6-21.117.00.67.1
Change In Accounts Receivable-25.1-48.1-11.4-44.0-20.70.00.00.0
Change In Accounts Payable41.050.140.330.87.622.73.710.1
Change In Inventories-9.2-8.4-3.2-4.4-3.4-0.50.00.0
Other Non-cash Items73.53.23.669.312.5-90.40.3-0.3
Cash from Operations-23.40.00.0-70.9-120.1-132.8-89.1-39.4
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-5.72.9-5.9-14.7-23.8-14.2-24.6-25.3-33.1-23.6
Depreciation & Amortization6.16.16.16.16.16.15.95.75.42.7
Stock-Based Compensation19.018.118.515.813.311.911.811.59.78.4
Change Working Capital-14.012.1-6.6-11.3-1.7-1.21.623.9-10.9-5.6
Change In Accounts Receivable-19.0-3.1-9.1-16.8-10.9-8.1-5.413.0-20.1-12.5
Change In Accounts Payable3.424.310.611.79.312.86.911.312.510.3
Change In Inventories-2.3-1.2-2.3-2.7-0.2-0.9-1.1-1.0-2.2-0.4
Other Non-cash Items0.70.4-0.12.21.11.51.6-0.642.60.6
Cash from Operations0.00.00.00.00.00.00.00.0-16.6-18.2
Cash Flow From Investing Activities TTM 2025202420232022202120202019
Capital Expenditure-15.8-1.0-1.0-0.1-0.3-19.0-0.2-0.3
Acquisitions27.10.00.0-212.80.0-19.00.00.0
Investments-61.9-97.4-89.0-27.3-132.3-198.0-74.6-152.0
Sales of Investment33.074.419.9153.0140.3157.6112.724.5
Other Investing Activities-43.90.00.0-20.00.0127.00.00.0
Cash from Investing-257.50.00.0-107.27.748.537.9-127.8
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.6-0.2-0.10.00.0-0.2-0.80.0-5.00.0
Acquisitions0.00.00.00.00.00.00.00.0239.8-212.8
Investments-11.5-20.9-31.5-33.5-11.5-15.6-61.90.00.00.0
Sales of Investment13.118.825.117.412.17.80.00.03.030.0
Other Investing Activities0.00.00.00.00.00.00.00.0-2.030.0
Cash from Investing0.00.00.00.00.00.00.00.0-2.0-182.8
Cash Flow From Financing Activities TTM 2025202420232022202120202019
Debt Repaid-115.50.00.0109.70.00.00.00.0
Debt Issued124.2317.89.6415.7-0.4-0.6-0.43.6
Issuance of Common Stock212.90.00.0216.7107.49.0131.967.2
Repurchase of Common Stock0.00.00.00.015.60.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.0
Other Financing Activities13.00.00.010.2-13.964.549.460.0
Cash from Financing217.40.00.0336.6109.173.5181.3127.2
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.00.00.0
Debt Issued318.8-0.11.7-0.60.11.19.0-0.62.1-1.8
Issuance of Common Stock0.00.00.00.00.00.00.00.0-0.2202.4
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.01.94.8
Cash from Financing0.00.00.00.00.00.00.00.01.8207.1
Cash position TTM 2025202420232022202120202019
Net Change in Cash-64.075.2-63.4158.3-3.3-10.7130.1-40.0
Closing Cash Balance233.2298.2222.9286.3128.0131.3142.112.0
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash15.753.916.4-10.7-0.5-10.1-69.316.5-16.75.8
Closing Cash Balance298.2282.0228.6212.2222.9223.4233.5302.8286.3303.1
Free Cash Flow TTM 2025202420232022202120202019
Free Cash Flow-39.254.99.3-91.1-120.4-151.8-89.3-39.6
Real Free Cash Flow-80.6-16.6-39.1-126.1-147.4-174.9-101.9-45.7
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow5.539.511.9-2.0-5.1-6.2-14.615.2-21.6-18.2
Real Free Cash Flow-13.621.4-6.6-17.8-18.3-18.1-26.43.7-31.3-26.6
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-140.4-17.4-1.4
P/S12.310.49.4
P/B19.96.35.2
P/FCF-272.6-51.6-1.5
Market cap$3.4$4.0
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets40.6 %17.1 %0 %
Debt to Income-1364.4 %-117.7 %0 %
Debt to Free cash flow-1926 %-2657.9 %0 %
Interest expense percentage-65 %-8.2 %44.7 %
Current ratio3.3 5.7 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-8 %-49.7 %0 %
ROA-3 %-29.9 %0 %
CapEx to Revenue0.1 %11 %0 %
RaD to Revenue0 %152.9 %0 %
ROEM1,618,981.4 156785.3

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin79.9 %52.1 %68.7 %
Operating margin-8.9 %-189 %35.5 %
Net margin-8.8 %-156.7 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %0 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding57.0 mil 33.4 mil
Employee count0.3 tis 0.2 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader